Diagnostic model study reveals that combining BMI and eGFR accurately identifies low fat-free mass index in health screening participants, suggesting an accessible alternative to body composition...
Background/Objectives: To develop and validate a simple prediction model for identifying individuals with low fat-free mass index (FFMI) using routinely available clinical variables. Methods: A total of 8736 individuals were included (mean age = 54.2 years). Among men, 1674 (40.1%) had a low FFMI (<18 kg/m2), while among women, 2160 (47.3%) had a low FFMI (<15 kg/m2). Candidate predictors were preprocessed to reduce redundancy and multicollinearity. Repeated LASSO logistic regression and XGBoost-based SHAP analysis were used to identify robust predictors, and sex-specific logistic regression models were developed using the final selected variables. Model performance was evaluated using 500 repeated 8:2 train-test splits, calibration analysis, risk stratification, and decision curve analysis (DCA). Results: BMI and estimated GFR (eGFR) were consistently selected as key predictors and were used to construct the final sex-specific models. The BMI-eGFR model showed excellent discrimination. Calibration plots demonstrated good agreement between predicted probabilities and observed event rates. Mean held-out sensitivities and specificities were 0.861/0.875 in men and 0.869/0.805 in women, respectively. DCA showed that the model provided a higher net benefit than treat-all or treat-none strategies over most of the evaluated threshold range of 0.05–0.50. Conclusions: Our model for predicting low FFMI may be helpful when direct muscle mass measurement is not readily available.
No takes yet. Share an insight, caveat, or question.
Nishikawa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: